Figure 1:

Cohort selection flow chart. Flow chart illustrates the selection process for HD sessions included in the study. A total of 39 371 eligible sessions were assessed for exposure to four classes of antihypertensive drugs: ACEIs/ARBs, alpha blockers, beta blockers and DHP-CCBs. It was possible for a session to have exposure status for multiple classes of antihypertensive drugs.